Dr. Richard Toselli, CEO of the InVivo Therapeutics Corporation a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries joins eHealth Radio and the Health News & Spinal Health Channels.
Listen to interview with host Eric Michaels and guest Dr. Richard Toselli discuss the following:
Prior to joining InVivo, Dr. Toselli served as Chief Medical Officer for Cochlear Limited. In that role, he was responsible for global clinical, regulatory, and medical affairs teams reporting to the CEO. Prior to that, Dr. Toselli served five years at Sanofi in various levels of increasing responsibility, including Vice President of Global Medical Affairs – Immunology and Inflammation, Biologics Division; Vice President of Global Medical Affairs and Head of the Biosurgery Discovery Performance Unit; and Vice President of Global Medical Affairs, Biosurgery.
Before his time at Sanofi, he served as Chief Medical/Technology Officer for Covidien Surgical, and earlier held various roles at DePuy Spine including Director of Medical Affairs, Worldwide Vice President of Research and Development, and Worldwide Vice President of Clinical Evidence and External Relations. He subsequently held the position of Vice President of Evidence-Based Medicine at Johnson & Johnson for the device sector.
Dr. Toselli’s previous academic positions include Assistant Professor at Brown University, Associate Professor, Director of Spine Center, and Associate Chief of Staff at the University of North Carolina (UNC), and Associate Professor at the University of Vermont. He holds a bachelor of arts from Providence College, his medical degree from Brown University, and a masters of business administration from the UNC’s Kenan-Flagler Business School. Dr. Toselli is a board-certified neurological surgeon.
InVivo Therapeutics Holdings Corporation is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. The company was founded in 2005 with proprietary technology co-invented by Robert Langer, Sc.D., Professor at Massachusetts Institute of Technology, and Joseph P. Vacanti, M.D., who then was at Boston Children’s Hospital and who now is affiliated with Massachusetts General Hospital. In January 2018, the company announced updated clinical evidence, including improvements in patients with acute spinal cord injury (SCI), from its INSPIRE study of the Neuro-Spinal Scaffold™. The publicly traded company is headquartered in Cambridge, MA.
Website: www.invivotherapeutics.com
Discussing Facelifts with Dr. Bajaj
Realeve Offers Scientific Breakthrough for Central Nervous System Disorders
How a High Fidelity Spine Surgery Simulator Is Using Virtual Reality to Train Young Surgeons
Giving Surgeons Control of the Incision
Latest trends and procedures in Plastic Surgery
Your Breast Lift Guide with Dr. Stephanie Teotia
Experience the Renewal of Spring with Kerasal® Foot and Nail Care
Genetic and Genetic Cancer Screening Saves Lives
Pelvic Floor Physical Therapy with Dr. Melanie Carminati
The Importance of Functional and Integrative Medicine and Why it Matters
Postpartum specialist says its important to support new moms after childbirth
Recognizing the Cycle of Ruptured Mother-Daughter Relationships
The Newest Fads in Health & Wellness
Global Trends in Medical Technology: A Marketer’s perspective
Fire, Air, Water & Earth: Renew Your Body’s Health & Your Mental Balance
For Lent and Easter: Explore a delicious, nutritious, and convenient meal
Hydrogen Water Tablets are Surging As a Natural Health Remedy
Fueling Your Vitality: Insights on Smart Supplement Choices
Semaglutide & New Rapid Weight Loss Medications and Their Effects on the Face and Neck
How Outdoor Group Travel Nurtures Mental Health
Join Podbean Ads Marketplace and connect with engaged listeners.
Advertise Today
Create your
podcast in
minutes
It is Free
The Relaxback UK Show
Good Nurse Bad Nurse
On Call With Dr. Anselm Anyoha
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive